INTRACRINE DYNAMICS OF CYP17A1 ACTIVITIES IN HUMAN CASTRATION RESISTANT PROSTATE CANCER

被引：0
|
作者：
Kosaka, Takeo
Miyajima, Akira
Maeda, Takahiro
Nagata, Hirohiko
Yasumizu, Yota
Kikuchi, Eiji
Oya, Mototsugu
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.1900
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
506
引用
收藏
页码：E207 / E208
页数：2
相关论文
共 50 条
  • [11] Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer
    Binder, Moritz
    Zhang, Ben Y.
    Hillman, David W.
    Kohli, Rhea
    Kohli, Tanvi
    Lee, Adam
    Kohli, Manish
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07)
  • [12] Synthesis of Fluorinated Analogs of Abiraterone, a Mechanism-based Inhibitor of CYP17A1 for Castration Resistant Prostate Cancer Therapy
    Veach, Darren R.
    Evans, Michael
    Sawyers, Charles L.
    Larson, Steven M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S227 - S227
  • [13] ANALYSIS OF UP-REGULATED CYP17A1 EXPRESSION UNDER ANTI-ANDROGEN STRATEGIES IN CASTRATION RESISTANT PROSTATE CANCER
    Heinrich, Elmar
    Tojan, Lutz
    Bremmer, Felix
    Strauss, Arne
    Thelen, Paul
    JOURNAL OF UROLOGY, 2013, 189 (04): : E131 - E131
  • [14] Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
    Mostaghel, Elahe A.
    Marck, Brett T.
    Plymate, Stephen R.
    Vessella, Robert L.
    Balk, Stephen
    Matsumoto, Alvin M.
    Nelson, Peter S.
    Montgomery, R. Bruce
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 5913 - 5925
  • [15] ODM-204, a novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer.
    Kallio, Pekka
    Oksala, Riikka
    Moilanen, Anu
    Riikonen, Reetta
    Rummakko, Petteri
    Malmstrom, Chira
    Mustonen, Mika V. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [16] Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer
    Maity, Sankar N.
    Titus, Mark A.
    Gyftaki, Revekka
    Wu, Guanglin
    Lu, Jing-Fang
    Ramachandran, S.
    Li-Ning-Tapia, Elsa M.
    Logothetis, Christopher J.
    Araujo, John C.
    Efstathiou, Eleni
    SCIENTIFIC REPORTS, 2016, 6
  • [17] Association of CYP17A1 single nucleotide polymorphism (SNP) with response to abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC).
    Zhang, Ben Miming
    Binder, Moritz
    Costello, Brian Addis
    Quevedo, Fernando
    Kohli, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [18] Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer
    Sankar N. Maity
    Mark A. Titus
    Revekka Gyftaki
    Guanglin Wu
    Jing-Fang Lu
    S. Ramachandran
    Elsa M. Li-Ning-Tapia
    Christopher J. Logothetis
    John C. Araujo
    Eleni Efstathiou
    Scientific Reports, 6
  • [19] Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
    Cai, Changmeng
    Chen, Sen
    Ng, Patrick
    Bubley, Glenn J.
    Nelson, Peter S.
    Mostaghel, Elahe A.
    Marck, Brett
    Matsumoto, Alvin M.
    Simon, Nicholas I.
    Wang, Hongyun
    Chen, Shaoyong
    Balk, Steven P.
    CANCER RESEARCH, 2011, 71 (20) : 6503 - 6513
  • [20] TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer
    Qin, Sisi
    Liu, Duan
    Kohli, Manish
    Wang, Liguo
    Vedell, Peter T.
    Hillman, David W.
    Niu, Nifang
    Yu, Jia
    Weinshilboum, Richard M.
    Wang, Liewei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (01) : 201 - 210
12345